It is now clear that men who meet NCCN criteria for very low- and low-risk forms of prostate cancer are almost invariably good candidates for initial management on active surveillance (i.e., just monitoring as opposed to immediate treatment). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, favorab le, intermediate, low, outcome, risk, surveillance, unfavorable | 8 Comments »
It would be easy to misinterpret (or at least “over-interpret”) a recent paper from the group at Johns Hopkins about the pathological outcomes of men initially diagnosed with very low-, low-, or “favorable” intermediate-risk localized disease and treated by immediate radical prostatectomy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, definable, pathology, risk, subset, surgery, surveillance | 11 Comments »
If you want to get a current update on the management of patients on active surveillance, you need to listed to/watch this presentation by Dr. Lawrence Klotz on the UroToday web site. But you will need 45 minutes. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, Klotz, risk, surveillance | 11 Comments »
One of the key ways in which we can (and do) assess the “value” of new types of medical test is by the degree to which they actually change the ways physicians act on the data and make decisions and/or recommendations about patient management. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active, biopsy, Diagnosis, risk, surveillance, Treatment | Leave a comment »
A new report in the Journal of Clinical Oncology suggests that younger patients had a somewhat lower risk for biopsy-based Gleason score upgrade while on active surveillance (AS) than older patients. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: active, age, progression, risk, surveillance | 6 Comments »
Dr. Michael Barry has been a long-time advocate for caution in the appropriate use of PSA testing and for awareness of the risks of over-treatment of low-risk forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, Diagnosis, PSA, risk, screening, surveillance, testing | Leave a comment »
Following his most recent check-in with his urologist, Howard tells us about things related to how the new USPSTF guidelines and tests like liquid biopsies might affect the monitoring of low-risk prostate cancer patients. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active, journey, surveillance, Wolinsky | Leave a comment »
